...
首页> 外文期刊>Japanese Journal of Pharmacology >Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits.
【24h】

Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits.

机译:持续的激动剂处理后,克隆的κ阿片受体转染的细胞中腺苷酸环化酶系统的敏感性:使用G蛋白alpha(i)2 / alpha(q)亚基的嵌合研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic and/or sustained opioid treatment has been shown to result in development of sensitization of the adenylyl cyclase (AC) system or cAMP overshoot. In this study, we investigated the molecular mechanism responsible for sensitization of the AC system using CHO cells co-expressing cloned kappa-opioid receptor and some chimeric G protein alpha(i2)/alpha(q) subunits. In CHO cells co-expressing the kappa-opioid receptor and pertussis toxin-insensitive chimeric alpha(i2)/alpha(q) subunits with alpha(i2) residues Met244-Asn331, despite pretreatment with pertussis toxin, acute treatment with the kappa-opioid-receptor-selective agonist U69,593 suppressed forskolin-stimulated cAMP accumulation, while sustained treatment with U69,593 (4 h) induced cAMP overshoot over the naive level by the kappa-opioid-receptor-selective antagonist norbinaltorphimine (sensitization of the AC system). On the other hand, in CHO cells co-expressing the kappa-opioid receptor and pertussis toxin-insensitive chimeric alpha(i2)/alpha(q) subunits without alpha(i2) residues Met244-Asn331, pretreatment with pertussis toxin completely blocked these acute and sustained effects of U69,593 on cAMP accumulation. These results suggested that the presence of the specific region of alpha(i2) (Met244-Asn331), which was reported to be responsible for the inhibition of AC, and continuous inhibition of AC by alpha(i2) is necessary for the development of sensitization.
机译:长期和/或持续的阿片类药物治疗已显示导致腺苷酸环化酶(AC)系统或cAMP过冲的发展。在这项研究中,我们调查了使用共表达克隆的κ阿片受体和一些嵌合G蛋白α(i2)/α(q)亚基的CHO细胞致敏AC系统的分子机制。在CHO细胞中共表达kappa阿片受体和百日咳毒素不敏感的嵌合alpha(i2)/ alpha(q)亚基与alpha(i2)残基Met244-Asn331,尽管用百日咳毒素进行了预处理,但还是用kappa阿片类药物进行了急性治疗受体选择性激动剂U69,593抑制了福斯高林刺激的cAMP积累,而持续使用U69,593(4 h)的治疗则由κ阿片受体选择性拮抗剂norbinaltorphimine导致幼稚水平的cAMP超调(AC系统敏化) )。另一方面,在共表达κ阿片受体和百日咳毒素不敏感的嵌合α(i2)/ alpha(q)亚基的CHO细胞中,不含α(i2)残基Met244-Asn331,用百日咳毒素预处理可完全阻断这些急性和U69,593对cAMP积累的持续影响。这些结果表明,α(i2)(Met244-Asn331)的特定区域的存在,据报道这是对AC的抑制作用,而α(i2)对AC的持续抑制是致敏作用发展所必需的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号